title: Lineage relationship of prostate cancer cell types based on gene expression.
abstract: BACKGROUND
  Prostate tumor heterogeneity is a major factor in disease management. Heterogeneity could be due to multiple cancer cell types with distinct gene expression. Of clinical importance is the so-called cancer stem cell type. Cell type-specific transcriptomes are used to examine lineage relationship among cancer cell types and their expression similarity to normal cell types including stem/progenitor cells.
  
  
  METHODS
  Transcriptomes were determined by Affymetrix DNA array analysis for the following cell types. Putative prostate progenitor cell populations were characterized and isolated by expression of the membrane transporter ABCG2. Stem cells were represented by embryonic stem and embryonal carcinoma cells. The cancer cell types were Gleason pattern 3 (glandular histomorphology) and pattern 4 (aglandular) sorted from primary tumors, cultured prostate cancer cell lines originally established from metastatic lesions, xenografts LuCaP 35 (adenocarcinoma phenotype) and LuCaP 49 (neuroendocrine/small cell carcinoma) grown in mice. No detectable gene expression differences were detected among serial passages of the LuCaP xenografts.
  
  
  RESULTS
  Based on transcriptomes, the different cancer cell types could be clustered into a luminal-like grouping and a non-luminal-like (also not basal-like) grouping. The non-luminal-like types showed expression more similar to that of stem/progenitor cells than the luminal-like types. However, none showed expression of stem cell genes known to maintain stemness.
  
  
  CONCLUSIONS
  Non-luminal-like types are all representatives of aggressive disease, and this could be attributed to the similarity in overall gene expression to stem and progenitor cell types.
authors: Department of Urology University of Washington, Seattle, WA 98195, USA.
authors: Laura E
authors: LE
authors: Pascal
authors: Ricardo Zn
authors: RZ
authors: Vêncio
authors: Robert L
authors: RL
authors: Vessella
authors: Carol B
authors: CB
authors: Ware
authors: Eneida F
authors: EF
authors: Vêncio
authors: Gareth
authors: G
authors: Denyer
authors: Alvin Y
authors: AY
authors: Liu
references: Prostate. 2004 Jul 1;60(2):98-108
references: 15162376
references: Proc Natl Acad Sci U S A. 2010 Feb 9;107(6):2610-5
references: 20133806
references: J Urol. 2010 Feb;183(2):433-40
references: 20006878
references: Nat Med. 1997 Jul;3(7):730-7
references: 9212098
references: J Urol. 2005 Feb;173(2):342-59
references: 15643172
references: BMC Urol. 2007 Dec 11;7:19
references: 18072977
references: Am J Pathol. 2004 Nov;165(5):1543-56
references: 15509525
references: J Cell Sci. 2001 Nov;114(Pt 21):3865-72
references: 11719553
references: Proc Natl Acad Sci U S A. 2003 Nov 11;100(23):13350-5
references: 14595015
references: Differentiation. 1999 Oct;65(2):113-8
references: 10550544
references: BMC Bioinformatics. 2006 Jun 06;7:286
references: 16756676
references: Stem Cells. 2007 Oct;25(10):2575-82
references: 17585167
references: BMC Cancer. 2009 Sep 08;9:317
references: 19737398
references: Cancer Biol Ther. 2007 May;6(5):763-8
references: 17592251
references: Prostate. 2009 Nov 1;69(15):1683-93
references: 19644960
references: Nat Genet. 2007 Jan;39(1):41-51
references: 17173048
references: Prostate. 2003 Jun 1;55(4):299-307
references: 12712409
references: Clin Cancer Res. 1996 Jun;2(6):1039-48
references: 9816265
references: Nature. 2009 Sep 24;461(7263):495-500
references: 19741607
references: Lab Invest. 1993 Feb;68(2):220-32
references: 7680083
references: Biostatistics. 2003 Apr;4(2):249-64
references: 12925520
references: BMC Genomics. 2006 Apr 25;7:92
references: 16638148
references: Proc Natl Acad Sci U S A. 2003 Apr 1;100(7):3983-8
references: 12629218
references: Prostate. 2009 Sep 1;69(12):1353-65
references: 19455603
references: J Androl. 1992 Nov-Dec;13(6):465-75
references: 1293128
references: Cancer Res. 1993 Oct 1;53(19):4720-6
references: 7691403
references: Prostate. 2003 Jun 1;55(4):239-46
references: 12712403
references: CA Cancer J Clin. 2000 Jan-Feb;50(1):7-33
references: 10735013
references: Prostate. 1996 Feb;28(2):98-106
references: 8604398
references: Cancer Res. 1999 Oct 1;59(19):5002-11
references: 10519415
references: Cancer Res. 2005 Dec 1;65(23):10946-51
references: 16322242
references: Curr Protoc Immunol. 2001 Nov;Chapter 20:Unit 20.5
references: 18432778
references: Cancer Microenviron. 2011 Jan 07;4(1):51-9
references: 21505567
references: Prostate. 2003 Apr 1;55(1):71-80
references: 12640663
references: BMC Urol. 2007 Apr 10;7:6
references: 17425799
references: Int J Clin Exp Pathol. 2009 Nov 10;3(2):128-38
references: 20126580
references: BMC Genomics. 2008 May 23;9:246
references: 18501003
references: Science. 2005 Oct 28;310(5748):644-8
references: 16254181
references: Mol Biol Cell. 2002 Apr;13(4):1274-81
references: 11950938
references: Int J Oncol. 2004 Aug;25(2):249-58
references: 15254720
references: Cancer Res. 2008 Mar 15;68(6):1820-5
references: 18339862
references: BMC Cancer. 2009 Dec 18;9:452
references: 20021671
references: Nature. 2008 Dec 11;456(7223):804-8
references: 18946470
references: Stem Cells. 2006 Dec;24(12):2677-84
references: 16916927
references: Science. 2000 Feb 25;287(5457):1431-3
references: 10688782
references: Am J Pathol. 2002 Jan;160(1):37-43
references: 11786396
references: Am J Pathol. 2002 Aug;161(2):705-15
references: 12163395
references: Prostate. 2010 Jun 1;70(8):875-82
references: 20127735
references: BMC Cancer. 2005 Jul 22;5:86
references: 16042785